Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?

Scheid, C. orcid.org/0009-0007-6539-226X, Eikema, D.-J., van Gelder, M. orcid.org/0000-0001-8698-4351 et al. (27 more authors) (2024) Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? Blood, 144 (4). pp. 445-456. ISSN 0006-4971

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 American Society of Hematology.

Keywords: Humans; Myelodysplastic Syndromes; Male; Female; Middle Aged; Aged; Retrospective Studies; Prognosis; Adult; Hematopoietic Stem Cell Transplantation; Neoplasm Staging; Treatment Outcome; Young Adult
Dates:
  • Published: 25 July 2024
  • Published (online): 10 May 2024
  • Accepted: 25 March 2024
  • Submitted: 21 August 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 16 Sep 2024 15:26
Last Modified: 16 Sep 2024 15:26
Status: Published
Publisher: American Society of Hematology
Refereed: Yes
Identification Number: 10.1182/blood.2023022273
Related URLs:
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics